Rosen Law Firm is encouraging investors who acquired Picard Medical, Inc. (PMI) securities during the period between September 2, 2025 and October 31, 2025 to consider joining an ongoing securities class action lawsuit. The firm has announced that investors interested in serving as lead plaintiff in the litigation must meet an April 13, 2026 deadline.
The class action alleges that Picard Medical engaged in a scheme involving materially false statements and material omissions regarding company operations. According to the complaint, the alleged misconduct includes a fraudulent stock promotion campaign utilizing social media platforms, coordinated insider selling through offshore accounts, and artificial trading activity designed to artificially elevate the company's stock price.
Investors who meet the class period requirements and wish to participate in the litigation are advised to consult with legal counsel regarding their options and potential eligibility. The firm notes that the lead plaintiff deadline represents a critical timeline for those considering involvement in the case.